BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nandu H, Wen PY, Huang RY. Imaging in neuro-oncology. Ther Adv Neurol Disord 2018;11:1756286418759865. [PMID: 29511385 DOI: 10.1177/1756286418759865] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Wright JS, Kaur T, Preshlock S, Tanzey SS, Winton WP, Sharninghausen LS, Wiesner N, Brooks AF, Sanford MS, Scott PJH. Copper-Mediated Late-stage Radiofluorination: Five Years of Impact on Pre-clinical and Clinical PET Imaging. Clin Transl Imaging 2020;8:167-206. [PMID: 33748018 DOI: 10.1007/s40336-020-00368-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
2 Xin Y, Yue X, Li H, Li Z, Cai H, Choudhary AK, Zhang S, Chugani DC, Langhans SA. PET imaging of medulloblastoma with an 18F-labeled tryptophan analogue in a transgenic mouse model. Sci Rep 2020;10:3800. [PMID: 32123231 DOI: 10.1038/s41598-020-60728-6] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer 2020;20:12-25. [PMID: 31806885 DOI: 10.1038/s41568-019-0224-7] [Cited by in Crossref: 90] [Cited by in F6Publishing: 85] [Article Influence: 30.0] [Reference Citation Analysis]
4 Shooli H, Dadgar H, Wáng YJ, Vafaee MS, Kashuk SR, Nemati R, Jafari E, Nabipour I, Gholamrezanezhad A, Assadi M, Larvie M. An update on PET-based molecular imaging in neuro-oncology: challenges and implementation for a precision medicine approach in cancer care. Quant Imaging Med Surg 2019;9:1597-610. [PMID: 31667145 DOI: 10.21037/qims.2019.08.16] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
5 Kassubek R, Müller HP, Thiele A, Kassubek J, Niessen HG. Advanced magnetic resonance imaging to support clinical drug development for malignant glioma. Drug Discov Today 2021;26:429-41. [PMID: 33249294 DOI: 10.1016/j.drudis.2020.11.023] [Reference Citation Analysis]
6 Al-Mubarak H, Vallatos A, Gallagher L, Birch J, Chalmers AJ, Holmes WM. Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma. Magn Reson Imaging 2022;85:121-7. [PMID: 34687852 DOI: 10.1016/j.mri.2021.10.030] [Reference Citation Analysis]
7 Bani-Sadr A, Eker OF, Berner LP, Ameli R, Hermier M, Barritault M, Meyronet D, Guyotat J, Jouanneau E, Honnorat J, Ducray F, Berthezene Y. Conventional MRI radiomics in patients with suspected early- or pseudo-progression. Neurooncol Adv 2019;1:vdz019. [PMID: 32642655 DOI: 10.1093/noajnl/vdz019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
8 Borja AJ, Hancin EC, Raynor WY, Ayubcha C, Detchou DK, Werner TJ, Revheim ME, Alavi A. A Critical Review of PET Tracers Used for Brain Tumor Imaging. PET Clin 2021;16:219-31. [PMID: 33589386 DOI: 10.1016/j.cpet.2020.12.004] [Reference Citation Analysis]
9 Werner JM, Lohmann P, Fink GR, Langen KJ, Galldiks N. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors. Molecules 2020;25:E1471. [PMID: 32213992 DOI: 10.3390/molecules25061471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
10 Di Bonaventura R, Montano N, Giordano M, Gessi M, Gaudino S, Izzo A, Mattogno PP, Stumpo V, Caccavella VM, Giordano C, Lauretti L, Colosimo C, D'Alessandris QG, Pallini R, Olivi A. Reassessing the Role of Brain Tumor Biopsy in the Era of Advanced Surgical, Molecular, and Imaging Techniques-A Single-Center Experience with Long-Term Follow-Up. J Pers Med 2021;11:909. [PMID: 34575685 DOI: 10.3390/jpm11090909] [Reference Citation Analysis]
11 Lohmann P, Kocher M, Steger J, Galldiks N. Radiomics derived from amino-acid PET and conventional MRI in patients with high-grade gliomas. Q J Nucl Med Mol Imaging 2018;62:272-80. [PMID: 29869488 DOI: 10.23736/S1824-4785.18.03095-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Chawla S, Shehu V, Gupta PK, Nath K, Poptani H. Physiological Imaging Methods for Evaluating Response to Immunotherapies in Glioblastomas. Int J Mol Sci 2021;22:3867. [PMID: 33918043 DOI: 10.3390/ijms22083867] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dwihapsari Y, Asdiantoro E, Maulidiyah N. On the Assessment of Image Inhomogeneity Using T2 Magnetic Resonance Imaging in Head Phantom for Radiotherapy Treatment Planning: Preliminary Study. Appl Magn Reson 2020;51:59-69. [DOI: 10.1007/s00723-019-01177-x] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Stopa BM, Juhász C, Mittal S. Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies. Mol Imaging 2021;2021:8874078. [PMID: 34194287 DOI: 10.1155/2021/8874078] [Reference Citation Analysis]
15 Lukas RV, Juhász C, Wainwright DA, James CD, Kennedy E, Stupp R, Lesniak MS. Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod. J Neurooncol 2019;141:111-20. [PMID: 30415456 DOI: 10.1007/s11060-018-03013-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
16 Fuenfgeld B, Mächler P, Fischer DR, Esposito G, Rushing EJ, Kaufmann PA, Stolzmann P, Huellner MW. Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination. PLoS One 2020;15:e0230618. [PMID: 32302317 DOI: 10.1371/journal.pone.0230618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Martins F, Gonçalves LG, Pojo M, Serpa J. Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas. Biomolecules 2020;10:E1370. [PMID: 32993063 DOI: 10.3390/biom10101370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Youssef G, Dietrich J. Ipilimumab: an investigational immunotherapy for glioblastoma. Expert Opin Investig Drugs 2020;29:1187-93. [PMID: 32945231 DOI: 10.1080/13543784.2020.1826436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]